======= DDX39B ======= == Gene Information == * **Official Symbol**: DDX39B * **Official Name**: DExD-box helicase 39B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7919|7919]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13838|Q13838]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DDX39B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DDX39B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/142560|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |DEAD| |Helicase C| |RNA-dependent ATPase activity| |negative regulation of DNA damage checkpoint| |negative regulation of cell cycle checkpoint| |U4 snRNA binding| |RNA secondary structure unwinding| |viral mRNA export from host cell nucleus| |U6 snRNP| |ATP-dependent protein binding| |positive regulation of cell growth involved in cardiac muscle cell development| |translocation of molecules into host| |translocation of molecules into other organism involved in symbiotic interaction| |U6 snRNA binding| |U4 snRNP| |transcription export complex| |regulation of DNA damage checkpoint| |regulation of cell growth involved in cardiac muscle cell development| |positive regulation of cardiac muscle cell differentiation| |positive regulation of cardiocyte differentiation| |positive regulation of cardiac muscle hypertrophy| |positive regulation of DNA-templated transcription, elongation| |positive regulation of muscle hypertrophy| |regulation of cell cycle checkpoint| |positive regulation of cardiac muscle tissue growth| |positive regulation of vascular smooth muscle cell proliferation| |regulation of cardiac muscle cell differentiation| |positive regulation of heart growth| |positive regulation of cardiac muscle tissue development| |positive regulation of organ growth| |regulation of vascular smooth muscle cell proliferation| |regulation of DNA-templated transcription, elongation| |regulation of cardiocyte differentiation| |spliceosomal complex assembly| |regulation of cardiac muscle hypertrophy| |regulation of cardiac muscle tissue growth| |positive regulation of striated muscle cell differentiation| |regulation of muscle hypertrophy| |regulation of heart growth| |RNA helicase activity| |positive regulation of DNA biosynthetic process| |positive regulation of striated muscle tissue development| |positive regulation of muscle organ development| |multi-organism transport| |multi-organism localization| |positive regulation of muscle tissue development| |regulation of cardiac muscle tissue development| |negative regulation of response to DNA damage stimulus| |mRNA 3-end processing| |regulation of muscle adaptation| |positive regulation of smooth muscle cell proliferation| |positive regulation of muscle cell differentiation| |spliceosomal complex| |regulation of organ growth| |regulation of striated muscle cell differentiation| |mRNA export from nucleus| |mRNA-containing ribonucleoprotein complex export from nucleus| |nuclear matrix| |regulation of DNA biosynthetic process| |ribonucleoprotein complex export from nucleus| |liver development| |positive regulation of translation| |ribonucleoprotein complex localization| |RNA export from nucleus| |hepaticobiliary system development| |regulation of striated muscle tissue development| |regulation of smooth muscle cell proliferation| |regulation of muscle tissue development| |RNA 3-end processing| |regulation of muscle organ development| |protein export from nucleus| |positive regulation of cellular amide metabolic process| |regulation of muscle cell differentiation| |mRNA transport| |interaction with host| |nuclear export| |positive regulation of cell growth| |positive regulation of developmental growth| |RNA transport| |nucleic acid transport| |positive regulation of DNA metabolic process| |establishment of RNA localization| |RNA localization| |regulation of response to DNA damage stimulus| |ribonucleoprotein complex assembly| |regulation of muscle system process| |ATPase activity| |nucleobase-containing compound transport| |ribonucleoprotein complex subunit organization| |protein-containing complex localization| |positive regulation of growth| |nucleocytoplasmic transport| |nuclear transport| |protein-containing complex binding| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions| |regulation of developmental growth| |regulation of translation| |regulation of DNA metabolic process| |positive regulation of cell cycle| |RNA splicing| |nuclear speck| |regulation of cellular amide metabolic process| |gland development| |regulation of cell growth| |ribonucleoprotein complex biogenesis| |mRNA processing| |posttranscriptional regulation of gene expression| |positive regulation of cell development| |regulation of system process| |regulation of growth| |mRNA metabolic process| |regulation of cellular response to stress| |symbiotic process| |interspecies interaction between organisms| |cellular protein-containing complex assembly| |RNA processing| |positive regulation of cell population proliferation| |regulation of cell development| |positive regulation of cell differentiation| |intracellular protein transport| |identical protein binding| |regulation of cell cycle| |positive regulation of developmental process| |RNA binding| |regulation of response to stress| |ATP binding| |protein transport| |intracellular transport| |peptide transport| |positive regulation of transcription, DNA-templated| |protein-containing complex assembly| |amide transport| |cellular protein localization| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |regulation of cell population proliferation| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |establishment of localization in cell| |nitrogen compound transport| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-2.2| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-2.14| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-2.05| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-1.8| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-1.71| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.7| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|1.72| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|1.72| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|1.72| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.78| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.78| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|1.8| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|1.8| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|1.86| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|1.88| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.91| |[[:results:exp494|Isoniazid 100μM R08 exp494]]|1.96| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.05| |[[:results:exp34|Rotenone 20μM R00 exp34]]|2.05| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|2.16| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.19| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|2.23| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 17/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|1/28| |bone|0/26| |breast|1/33| |central nervous system|0/56| |cervix|2/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|2/16| |kidney|0/21| |liver|1/20| |lung|1/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1487 * **Expression level (log2 read counts)**: 9.32 {{:chemogenomics:nalm6 dist.png?nolink |}}